drug
osilodrostat phosphate
Marketedupdated 5mo agoby Recordati Rare Diseases Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(4)
approval · 4
Mar 6, 2020
approval
ISTURISA (OSILODROSTAT PHOSPHATE) — FDA approval
osilodrostat phosphate
→
Apr 15, 2025
approval
ISTURISA (OSILODROSTAT PHOSPHATE) — FDA approval
osilodrostat phosphate
→
Jul 3, 2025
approval
ISTURISA (OSILODROSTAT PHOSPHATE) — FDA approval
osilodrostat phosphate
→
Nov 4, 2025
approval
ISTURISA (OSILODROSTAT PHOSPHATE) — FDA approval
osilodrostat phosphate
→
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 6, 2027
153 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (18)
- Oct 12, 2035method-of-use (U-2770)US 10709691
- Oct 12, 2035method-of-use (U-2770)US 10709691
- Oct 12, 2035method-of-use (U-2770)US 10709691
- Jul 6, 2035formulationUS 10143680
- Jul 6, 2035formulationUS 10143680
- Jul 6, 2035formulationUS 10143680
- Jan 13, 2031method-of-use (U-2770)US 86098624.3y
- Jan 13, 2031method-of-use (U-2770)US 86098624.3y
- Jan 13, 2031method-of-use (U-2770)US 86098624.3y
- Jan 13, 2031compositionUS 94347544.3y
- Jan 13, 2031compositionUS 94347544.3y
- Jan 13, 2031compositionUS 94347544.3y
- Mar 27, 2029compositionUS 83140972.5y
- Mar 27, 2029compositionUS 83140972.5y
- Mar 27, 2029compositionUS 83140972.5y
- Aug 23, 2026compositionUS 8835646
- Aug 23, 2026compositionUS 8835646
- Aug 23, 2026compositionUS 8835646
FDA exclusivities (3)
- Mar 6, 2027ODE-286Orphan Drug (7y)153d
- Mar 6, 2027ODE-286Orphan Drug (7y)153d
- Mar 6, 2027ODE-286Orphan Drug (7y)153d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that